ISSN: 1309 - 3843 E-ISSN: 1307 - 7384
FİZİKSEL TIP VE REHABİLİTASYON
BİLİMLERİ DERGİSİ
www.jpmrs.com
Kayıtlı İndexler


OLGU SUNUMLARI

COVID-19 Aşılaması Sonrası Parsonage-Turner Sendromu: Klinik, Elektromiyografik Bulgular ve Rehabilitasyon Yaklaşımı
Parsonage-Turner Syndrome Following COVID-19 Vaccination: Clinical, Electromyographic Findings and Rehabilitation Approach
Received Date : 26 Jun 2024
Accepted Date : 23 Oct 2024
Available Online : 31 Oct 2024
Doi: 10.31609/jpmrs.2024-104481 - Makale Dili: EN
Turkiye Klinikleri Journal of Physical Medicine and Rehabilitation Sciences. 2025;28(1):99-102
ÖZET
Parsonage-Turner sendromu (PTS), koronavirüs hastalığı-2019 [coronavirus disease-2019 (COVID-19)] enfeksiyonu veya aşısını takiben nadir görülen bir durumdur. Patofizyoloji, genetik yatkınlığı olan bireylerde brakial pleksus sinir liflerine karşı bağışıklık aracılı inflamatuar reaksiyonu içerebilir. Bu yazıda, COVID-19 aşısını takiben PTS klinik tablosuyla başvuran bir hastanın klinik ve elektromiyografik özelliklerini tanımlıyoruz. Hastanın semptomları başlamadan bir hafta önce COVID-19 aşısı uygulanmıştı. Hastaya detaylı nörolojik muayene ve ardından sinir iletim ve elektromiyografi çalışması yapıldı. Hastanın takip muayenesinde kol ağrısında tam iyileşme ve kas güçlerinde düzelme sağlandı. PTS, COVID-19 aşısından sonra ortaya çıkabilir ve akut brakial pleksopatiye işaret eden semptom ve bulguları olan hastalarda düşünülmelidir.
ABSTRACT
Parsonage-Turner syndrome (PTS) following coronavirus disease-2019 (COVID-19) infection or vaccination is rare. The pathophysiology may involve an immune-mediated inflammatory reaction against brachial plexus nerve fibers in a genetically predisposed individual. We describe the clinical and electromyographic features of 1 patients presenting with the clinical picture of PTS following COVID- 19 vaccination. The patient had received the COVID-19 vaccine within one week prior to the onset of symptoms. Patient underwent detailed neurological examination followed by nerve conduction and electromyography study. The patient attained complete resolution of the arm pain at follow up and had recovery in strength. PTS may occur after the COVID-19 vaccine and should be suspected in patients with symptoms and signs suggestive of acute brachial plexopathy.
REFERENCES
  1. Feinberg JH, Radecki J. Parsonage-turner syndrome. HSS J. 2010;6:199-205. [Crossref]  [PubMed]  [PMC] 
  2. van Alfen N. Clinical and pathophysiological concepts of neuralgic amyotrophy. Nat Rev Neurol. 2011;7:315-22. [Crossref]  [PubMed] 
  3. Shaikh MF, Baqai TJ, Tahir H. Acute brachial neuritis following influenza vaccination. BMJ Case Rep. 2012;2012:bcr2012007673. [Crossref]  [PubMed]  [PMC] 
  4. Milner CS, Kannan K, Iyer VG, et al. Parsonage-Turner syndrome: clinical and epidemiological features from a hand surgeon's perspective. Hand (N Y). 2016;11:227-31. [Crossref]  [PubMed]  [PMC] 
  5. England JD, Sumner AJ. Neuralgic amyotrophy: an increasingly diverse entity. Muscle Nerve. 1987;10:60-8. [Crossref]  [PubMed] 
  6. Magee KR, Dejong RN. Paralytic brachial neuritis. Discussion of clinical features with review of 23 cases. JAMA. 1960;174:1258-62. [Crossref]  [PubMed] 
  7. Gaskin CM, Helms CA. Parsonage-Turner syndrome: MR imaging findings and clinical information of 27 patients. Radiology. 2006;240:501-7. [Crossref]  [PubMed] 
  8. Suarez GA, Giannini C, Bosch EP, et al. Immune brachial plexus neuropathy: suggestive evidence for an inflammatory-immune pathogenesis. Neurology. 1996;46:559-61. [Crossref]  [PubMed] 
  9. Debeer P, De Munter P, Bruyninckx F, et al. Brachial plexus neuritis following HPV vaccination. Vaccine. 2008;26:4417-9. [Crossref]  [PubMed] 
  10. Mahajan S, Zhang F, Mahajan A, et al. Parsonage Turner syndrome after COVID-19 vaccination. Muscle Nerve. 2021;64:E3-E4. [Crossref]  [PubMed]  [PMC] 
  11. Diaz-Segarra N, Edmond A, Gilbert C, et al. Painless idiopathic neuralgic amyotrophy after COVID-19 vaccination: a case report. PM R. 2022;14:889-91. [Crossref]  [PubMed]  [PMC] 
  12. Han CY, Tarr AM, Gewirtz AN, et al. Brachial plexopathy as a complication of COVID-19. BMJ Case Rep. 2021;14:e237459. [Crossref]  [PubMed]  [PMC] 
  13. Thomas SJ, Moreira ED Jr, Kitchin N, et al; C4591001 Clinical Trial Group. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N Engl J Med. 2021;385:1761-73. [PubMed]  [PMC] 
  14. van Alfen N, van Engelen BG, Hughes RA. Treatment for idiopathic and hereditary neuralgic amyotrophy (brachial neuritis). Cochrane Database Syst Rev. 2009;2009:CD006976. [Crossref]  [PubMed]  [PMC] 
  15. Yu DK, Cho YJ, Heo DH, et al. Neuroradiologic and neurophysiologic findings of neuralgic amyotrophy. J Korean Neurosurg Soc. 2010;48:423-8. [Crossref]  [PubMed]  [PMC] 
  16. Gerhard A, Raeder V, Pernice HF, et al. Neurological symptoms after COVID-19 vaccination: a report on the clinical presentation of the first 50 patients. J Neurol. 2023;270:4673-7. [Crossref]  [PubMed]  [PMC] 
  17. Chatterjee A, Chakravarty A. Neurological complications following COVID-19 vaccination. Curr Neurol Neurosci Rep. 2023;23:1-14. [Crossref]  [PubMed]  [PMC] 
  18. Mohseni Afshar Z, Sharma A, Babazadeh A, et al. A review of the potential neurological adverse events of COVID-19 vaccines. Acta Neurol Belg. 2023;123:9-44. [Crossref]  [PubMed]  [PMC]